Improved Chemosensitivity in Metastatic Castration‐Resistant Prostate Cancer: The Synergistic Effects of S‐Adenosylmethionine and Cabazitaxel

ABSTRACT Metastatic castration‐resistant prostate cancer (mCRPC) is the most aggressive kind of prostate cancer (PCa). Because the traditional taxane‐based therapy is ineffective, cabazitaxel (CBZ), a second‐generation, semisynthetic taxane, has been developed. Despite it demonstrating efficacy in p...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Roberta Arpino, Francesca Cadoni, Cristina Pagano, Laura Coppola, Vitale Del Vecchio, Aditya Nigam, Laura Mosca, Marina Porcelli
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2026-04-01
Serija:	Cancer Medicine
Teme:	adjuvant chemoterapy apoptosis cabazitaxel metastatic castration‐resistant prostate cancer oxidative stress S‐adenosyl‐L‐methionine
Online dostop:	https://doi.org/10.1002/cam4.71784
Oznake:	Označite Brez oznak, prvi označite!